Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | TLR2 | O60603 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31094895 | 0.94 | PTPN1 (0.47) | PTPN1KMT2AMDM2 | |
| SCHEMBL29358858 | 0.93 | TLR2 (0.46) | PTPN1MDM2TLR2 | |
| SCHEMBL29358136 | 0.92 | TLR2 (0.46) | PTPN1MDM2TLR2 | |
| SCHEMBL30541991 | 0.91 | KMT2A (0.42) | PTPN1KMT2AMDM2TLR2 | |
| SCHEMBL24235686 | 0.91 | PTPN1 (0.54) | PTPN1KMT2AMDM2 | |
| SCHEMBL27153600 | 0.90 | CASP3 (0.48) | KMT2AMDM2 | |
| SCHEMBL27153601 | 0.90 | CASP3 (0.48) | KMT2AMDM2 | |
| SCHEMBL24235738 | 0.89 | PTPN1 (0.56) | PTPN1KMT2AMDM2 | |
| SCHEMBL23728660 | 0.89 | MDM2 (0.53) | PTPN1MDM2TLR2 | |
| SCHEMBL23728661 | 0.89 | MDM2 (0.53) | PTPN1MDM2TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600759-B2 | Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs | ENZENE BIOSCIENCES LIMITED (IN) | 2026-04-14 | — | — | US | claimed |
| WO-2025094036-A1 | A PROCESS FOR THE PREPARATION OF LIRAGLUTIDE | PIRAMAL PHARMA LIMITED (IN) | 2025-05-08 | — | — | WO | claimed |
| CN-119080911-B | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-116120427-B | Semex lattice Synthesis method of lupeptide | 浙江九洲药业股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119080911-A | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-117986349-B | Semex lattice preparation method of lupeptide | 福建基诺厚普生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| WO-2024159569-A1 | METHOD FOR SYNTHESIZING SEMAGLUTIDE | 浙江九洲药业股份有限公司 | 2024-08-08 | — | — | WO | claimed |
| CN-118240060-A | Preparation method of GLP-1 receptor and GCG receptor co-excited polypeptide derivative | 惠升生物制药股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118147106-A | Preparation methods of enzyme, complex enzyme, immobilized enzyme and Tirzepatide | 深圳瑞德林生物技术有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-118005767-A | Method for preparing Tirzepatide by combining solid and liquid | 柏佳薇(深圳)生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117986349-A | Preparation method of semaglutin | 福建基诺厚普生物科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| US-20220153804-A1 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | ENZENE BIOSCIENCES LIMITED (IN) | 2022-05-19 | — | — | US | claimed |
| EP-3941936-A2 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | Enzene Biosciences Ltd. (IN) | 2022-01-26 | — | — | EP | claimed |
| US-12600759-B2 | Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs | ENZENE BIOSCIENCES LIMITED (IN) | 2026-04-14 | — | — | US | disclosed |
| US-12589158-B2 | GLP-1/GIP dual agonist, preparation method and use thereof | HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) | 2026-03-31 | — | — | US | disclosed |
| EP-4662222-A1 | PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE | Fresenius Kabi Oncology Ltd (IN) | 2025-12-17 | — | — | EP | disclosed |
| EP-3774838-B1 | LIXISENATIDE SYNTHESIS WITH CAPPING | SANOFI AVENTIS DEUTSCHLAND (DE) | 2022-08-10 | — | — | EP | disclosed |
| US-20220153804-A1 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | ENZENE BIOSCIENCES LIMITED (IN) | 2022-05-19 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-3941936-A2 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | Enzene Biosciences Ltd. (IN) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153804-A1 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | GLP1R, GIPR, GCGR | PTPN1 330/4885KMT2A 2767/4885MDM2 3435/4885 |
| US-12589158-B2 | GLP-1/GIP dual agonist, preparation method and use thereof | GLP1R, GIPR, IAPP | PTPN1 1424/4885KMT2A 942/4885MDM2 3931/4885 |
| US-12600759-B2 | Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs | GLP1R, GIPR, GCG | PTPN1 2094/4885KMT2A 2737/4885MDM2 2390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.